Real-world safety assessment of burosumab: a pharmacovigilance study utilizing the FDA adverse event reporting system.
Saved in:
| Title: | Real-world safety assessment of burosumab: a pharmacovigilance study utilizing the FDA adverse event reporting system. |
|---|---|
| Authors: | Chen T; The Department of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi, 530021, China., Liang M; The Department of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi, 530021, China. liangm@gxmu.edu.cn. |
| Source: | Orphanet journal of rare diseases [Orphanet J Rare Dis] 2026 Feb 28; Vol. 21 (1). Date of Electronic Publication: 2026 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1750-1172 |
|---|---|
| DOI: | 10.1186/s13023-026-04267-9 |
